alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

109TH CONGRESS 

2D SESSION H. R. 4955 

To suspend temporarily the duty on Hydrated Hydroxypropyl Methylcellulose. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 14, 2006 

Mrs. MCCARTHY introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To suspend temporarily the duty on Hydrated Hydroxypropyl 

Methylcellulose. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. HYDRATED HYDROXYPROPYL 

4 METHYLCELLULOSE. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 


bajohnson on PROD1PC69 with BILLS
2 

•HR 4955 IH 

‘‘ 9902.39.13 Hydrated Hydroxypropyl 

Methylcellulose; Cellulose, 2- 

hydroxypropyl methyl ether; 

Cellulose; Hydroxypropyl 

methyl ether (CAS No. 

9004–65–3)(provided for in 

subheading 3912.39.00) ...... Free No change No change On or before 

12/31/2009 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


bajohnson on PROD1PC69 with BILLS
No. 09-9009.

#### John E. Winfield, Petitioner v. Don Roper, Superintendent, Potosi Correctional Center.

559 U.S. 1073, 130 S. Ct. 2100,

176 L. Ed. 2d 732,

2010 U.S. LEXIS 3419.

April 19, 2010.

Petition for writ of cer-tiorari to the Supreme Court of Missouri denied.

Same case below, 292 S.W.3d 909.
EXHIBIT 10.2

 

ENDORSEMENT TO 10% SENIOR SECURED CONVERTIBLE NOTE

 

Precision Optics Corporation, Inc.
 New York, New York
 February 25, 2011

 

The 10% Senior Secured Convertible Note dated June 25, 2008 and amended December 11, 2008, June 25, 2010 July 26, 2010, September 15, 2010, October 15, 2010, November 15, 2010, November 30, 2010, December 1, 2010, December 3, 2010 and December 17, 2010, January 10, 2011,  January 24, 2011, and February 7, 2011 (the “Note”) of Precision Optics Corporation, Inc., a Massachusetts corporation (the “Company”), payable to the order of Special Situations Private Equity Fund, L.P. (the “Holder”) in an aggregate principal amount of $275,000 and to which the Endorsement is affixed is hereby amended in the following respects:

 

1.             The term “Stated Maturity Date” is hereby restated to be “March 11, 2011.”

 

2.                                       Except as expressly amended by this Endorsement, the Note remains in full force and effect and the Company hereby reconfirms its obligations thereunder.

 

IN WITNESS WHEREOF, the Company has caused this Endorsement to be duly executed, and the Holder has caused this Endorsement to be duly accepted, by their respective duly authorized representatives as of the day and year first above written.

 

 

	
 
    	
PRECISION   OPTICS CORPORATION, INC.
    
	
 
    	
 
    
	
 
    	
By
    	
/s/   Joseph N. Forkey
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Name:   Joseph N. Forkey
    
	
 
    	
 
    	
Title:   Chief Executive Officer
    
	
 
    	
 
    
	
Accepted:
    	
 
    
	
 
    	
 
    
	
SPECIAL   SITUATIONS PRIVATE EQUITY FUND, L.P.
    	
 
    
	
 
    	
 
    
	
By:
    	
/s/   Adam Stettner
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
Name:   Adam Stettner
    	
 
    
	
 
    	
Title:   General Partner
No. 09-8126.

#### Omari Sharifa Coley, Petitioner v. United States.

559 U.S. 1071, 130 S. Ct. 2093,

176 L. Ed. 2d 729,

2010 U.S. LEXIS 3465.

April 19, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Eleventh Circuit denied.

Same case below, 336 Fed. Appx. 933.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. 

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Mental Health Special Emphasis Panel; Center for AIDS Intervention Research Core Support.                     

*Date:*                         March 20, 2009.                     

*Time:*                         1 p.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).                     

*Contact Person:*                         Enid Light, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Boulevard, Room 6132, MSC 9608, Bethesda, MD 20852-9608, 301-443-0322,                         *elight@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS)

      ( print page 9255)    
Dated: February 25, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-4476 Filed 3-2-09; 8:45 am] 

BILLING CODE 4140-01-P
No. 09-9722.

#### Octavio Rojas-Rodriguez, Petitioner v. United States.

559 U.S. 1084, 130 S. Ct. 2133,

176 L. Ed. 2d 752,

2010 U.S. LEXIS 3161.

April 19, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Fifth Circuit denied.
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A24A1146. CORDARRIEL GREEN v. HOMETOWN COMMUNITIES

PROPERTY MANAGEMENT.

Hometown Communities Property Management filed a dispossessory action

against Cordarriel Green in magistrate court. After the magistrate court entered

judgment in favor of Hometown, Green appealed to superior court, which also ruled

in favor ofHometown. On May 24, 2021, the superior court entered a“Final Order,”

ordering the clerk to return to Green funds he had paid into the court registry and

giving Green ten days to remove his mobile home from the premises at issue. On June

22, 2021, Green filed a notice of appeal to this Court. We lack jurisdiction.

“[A]ppeals from decisions of the superior courts reviewing decisions of lower

courts by certiorari or de novo proceedings shall be by application for discretionary

appeal.” Bullock v. Sand, 260 Ga. App. 874, 875 (581 SE2d 333) (2003) (punctuation

omitted); accord OCGA§ 5-6-35 (a) (1).“Compliance with the discretionary appeals

procedure is jurisdictional.” Smoak v. Dept. of Human Resources, 221 Ga. App. 257,

257 (471 SE2d 60) (1996). Green’s failure to follow the proper procedure deprives us

of jurisdiction over this appeal.

Furthermore, even if a direct appeal were proper here, this appeal is untimely.

While a notice of appeal generally may be filed within 30 days of entry of the order on

appeal, see OCGA § 5-6-38 (a), appeals in dispossessory actions must be filed within

7 days of the date the judgment was entered. See OCGA § 44-7-56 (2022)1; Radio

1 OCGA§ 44-7-56was amended in 2022. Ga. L. 2022, pp. 767, 797, § 2-35. The

prior version of the statue applies here because the amended version applies only to

April 18, 2024
Sandy Springs v. Allen Road Joint Venture, 311 Ga. App. 334, 335-336 (715 SE2d 752)

(2011); Ray M.Wright, Inc. v. Jones, 239 Ga.App. 521, 522-523 (521 SE2d 456) (1999).

Green’s appeal was untimely filed 29 days after the superior court’s order was

entered.

For the above reasons, this appeal is hereby DISMISSED for lack of

jurisdiction.

Court of Appeals of the State of Georgia

Clerk’s Office,Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

petitions for review filed in superior or state court on or after July 1, 2023. Ga. L.

2022, pp. 767, 801, § 3-1.

04/18/2024
----

Exhibit 32 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

The undersigned, YuChang, the Chief Executive Officer and President and Lijun Peng, the ChiefFinancial Officer of CHINA AGRITECH, INC. (the "Company"), DO HEREBY CERTIFYthat: 

1.    The Company’s Quarterly Report on Form 10-QSB for the quarter ended March 31,2006 (the "Report"), fully complies with the requirements of Section 13(a) ofthe Securities Exchange Act of 1934; and 

2.     Informationcontained in the Report fairly presents, in all material respects, the financialcondition and results of operation of the Company. 

IN WITNESS WHEREOF, each of theundersigned has executed this statement this 22nd day of May 2006.

| /s/ Yu Chang                          |   |
|---------------------------------------|--------|
| Yu      Chang                         |
| Chief Executive Officer and President |
| (Principal Executive Officer)         |
|                                  |
| /s/ Lijun Peng                        |   |
| Lijun Peng                            |
| Chief Financial Officer               |

A signed original of this written statementrequired by Section 906 has been provided to CHINA AGRITECH, INC. and will beretained by CHINA AGRITECH, INC. and furnished to the Securities and ExchangeCommission or its staff upon request. 

----
##### 



EXHIBIT 32.2 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of IPC Acquisition Corp. (the Company) on Form 10-Q
for the period ended December 31, 2004, as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, Timothy Whelan, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that: 1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and 2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. By:
    
    /s/ Timothy WhelanTimothy WhelanChief Financial OfficerFebruary 11, 2005
 A signed original of this written statement required by Section 906 has been provided to IPC
Acquisition Corp. and will be retained by IPC Acquisition Corp. and furnished to the Securities and
Exchange Commission or its staff upon request.
----

----

|   | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

|           |   |              |                                                                                       |                            |   |
|----------------|--------|-------------------|--------------------------------------------------------------------------------------------|---------------------------------|--------|
|           |   | LAXAI PHARMA LTD. |                                                                                       |
|           |   |              |                                                                                       |                            |
| April 15, 2010 |   | By:               | /s/    J. Ram Ajjarapu         |                            |
|           |   |              |                                                                                       | J Ram Ajjarapu                  |   |
|           |   |              |                                                                                       | Interim Chief Financial Officer |   |

----

----
No. 09-8529.

#### William Walls, Petitioner v. Larry J. Philips.

559 U.S. 1011, 130 S. Ct. 1889,

176 L. Ed. 2d 373,

2010 U.S. LEXIS 2710.

March 22, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
No. 09-8864.

#### Robert L. Henry, Petitioner v. Florida Department of Corrections, et al.

559 U.S. 1050, 130 S. Ct. 2367,

2010 U.S. LEXIS 2981.

176 L. Ed. 2d 564,

April 5, 2010.

Petition for writ of certio-rari to the United States Court of Appeals for the Eleventh Circuit denied.
file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM] INITIAL REVIEW ENGINEERING REPORT PMN: 13-0055 , 0056 Focus Ready Draft 12/13/2012

ENGINEER: Hall \ REC

MSDS: Yes Label: No

Gen Eqpt: Chemical resistant protective gloves; safety glasses with side-shields or tightly fitting safety goggles (chemical goggles); and body protection such as head protection, apron, protective boots, and chemical-protection suit. Respirator: Wear a NIOSH-certified (or equivalent) organic vapour/particulate respirator. For situations where the airborne concentrations may exceed the level for which an air purifying respirator is effective, or where the levels are unknown or Immediately Dangerous to Life or Health (IDLH), use NIOSH-certified full facepiece pressure demand self-contained breathing apparatus (SCBA) or a full facepiece pressure demand supplied-air respirator (SAR) with escape provisions. Health Effects: May cause severe irritation to eyes.; inhalation may cause respiratory irritation; and ingestion may result in severe irritation or burns of the mouth, esophagus and stomach.

TLV/PEL:

None Establishedfile:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM] SAT (concerns) (11/14/2012):

Migration to groundwater: Moderate to Rapid PBT rating: P1B1T2 PBT Rating: P1B1T2 SAT concerns ratings are identical for P13-0055 and P13-0056. Health: 2 Dermal, Drinking Water, Inhalation Eco: 3 Water (All releases to water with a CC = 1.00 ppb)

OCCUPATIONAL EXPOSURE RATING: 2-3B

NOTES & KEY ASSUMPTIONS: Generated by the 06/07/2005 version of ChemSTEER.file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM] INITIAL REVIEW ENGINEERING REPORT PMN: 13-0055 , 0056file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM]file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM] b) Hazard Rating for health of 2 or greater? 2 Yesfile:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM] INITIAL REVIEW ENGINEERING REPORT PMN: 13-0055 , 0056file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM]file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM]file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM]file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM]file:///C|/Documents%20and%20Settings/jquennev/Desktop/p130055c.eng.txt[3/4/2013 12:03:06 PM]
Director Compensation Schedule



 Exhibit 10(x) 
 INVACARE CORPORATION 
 BOARD OF DIRECTORS COMPENSATION

  

							
	 Retainer Fee
	  	$	60,000	  	  	
	 Additional Retainer Fees
	  				  	
	 Lead Director:
	  	$	15,000	  	  	
	 Audit Chair:
	  	$	15,000	  	  	
	 Compensation Chair:
	  	$	15,000	  	  	
	 Other Committee Chairs:
	  	$	10,000	  	  	
	 Fees for Meetings in excess of 24 in a year
	  	$	1,500	  	  	
		
	 Equity Components
	  	 	Restricted stock award grant value of $90,000
		
		  	 
 	For new directors - non-qualified stock option grant equal to
$150,000 divided by the market price on date elected
		
	 Non-Employee Director Elective Stock Option Program
	  	 
 	Non-employee directors may elect to defer all or a portion of their
following year director fees into discounted stock options
<PAGE>
                                                                      EXHIBIT 23
 
                       CONSENT OF INDEPENDENT ACCOUNTANTS
 
    We  consent to the  incorporation by reference in  the Form S-8 registration
statements of  the  Oryx  Energy  Company Long-Term  Incentive  Plan  (File  No.
33-25032),   the  Oryx  Energy  Company  Capital  Accumulation  Plan  (File  No.
33-24918), the  Oryx Energy  Company  1992 Long-Term  Incentive Plan  (File  No.
33-42695)  and the Form S-3 registration statements of Oryx Energy Company (File
No.'s 33-33361, 33-36799 and 33-45611), of  our report dated February 19,  1996,
on our audit of the consolidated financial statements of Oryx Energy Company and
its  Subsidiaries as  of December 31,  1995 and 1994  and for each  of the three
years in the  period ended December  31, 1995, which  report is incorporated  by
reference  in this Form 10-K from page 41 of the Oryx Energy Company 1995 Annual
Report to Shareholders.
 
                                          COOPERS & LYBRAND L.L.P.
 
Dallas, Texas
March 27, 1996
# C_2016094EN.01000601.xml

| 10.3.2016 | EN | Official Journal of the European Union | C 94/6 |
| --- | --- | --- | --- |

10.3.2016

EN

Official Journal of the European Union

C 94/6

---

Types of gas and the corresponding supply pressures according to Article 2(2) of Directive 2009/142/EC of the European Parliament and of the Council relating to appliances burning gaseous fuels

(2016/C 94/03)

(This publication is based on information received by the Commission from the Member States)

(This publication is based on information received by the Commission from the Member States)

| Country | Gas family | Wobbe index (gross) in | Supply pressure in mbar |
| --- | --- | --- | --- |
| MJ/m3 or kWh/m3

  (0 °C) | MJ/m3 or kWh/m3

  (15 °C) | Min. | Nom. | Max. |
| Denmark | FIRST
  Group a | 23,60-26,20 MJ/m3

  6,56-7,28 kWh/m3 | 22,37-24,84 MJ/m3

  6,21-6,90 kWh/m3 | 6 (1) | 8 (1) | 15 (1) |
| SECOND
  Group H | 50,76-55,80 MJ/m3
   (2)
   (3)

  14,10-15,5 kWh/m3
   (2)
   (3) | 48,12-52,90 MJ/m3
   (2)
   (3)

  13,37-14,69 kWh/m3
   (2)
   (3) | 17 (1) | 20 (1) | 25 (1) |
| THIRD
  Group B/P | 76,90-92,10 MJ/m3

  21,36-25,58 kWh/m3 | 72,90-87,31 MJ/m3

  20,25-24,25 kWh/m3 | 25 (1) | 30 (1) | 35 (1) |

Country

Gas family

Wobbe index (gross) in

Supply pressure in mbar

MJ/m3 or kWh/m3

3

3

(0 °C)

MJ/m3 or kWh/m3

3

3

(15 °C)

Min.

Nom.

Max.

Denmark

FIRST

Group a

23,60-26,20 MJ/m3

3

6,56-7,28 kWh/m3

3

22,37-24,84 MJ/m3

3

6,21-6,90 kWh/m3

3

6 (1)

1

8 (1)

1

15 (1)

1

SECOND

Group H

50,76-55,80 MJ/m3
   (2)
   (3)

3

2

3

14,10-15,5 kWh/m3
   (2)
   (3)

3

2

3

48,12-52,90 MJ/m3
   (2)
   (3)

3

2

3

13,37-14,69 kWh/m3
   (2)
   (3)

3

2

3

17 (1)

1

20 (1)

1

25 (1)

1

THIRD

Group B/P

76,90-92,10 MJ/m3

3

21,36-25,58 kWh/m3

3

72,90-87,31 MJ/m3

3

20,25-24,25 kWh/m3

3

25 (1)

1

30 (1)

1

35 (1)

1

---

(1)  Inlet pressure for the appliances in mbar.

1

(2)  Abnormal supply conditions: provided that the Danish Safety Technology Authority has approved a special contingency plan allowing supply in an abnormal supply range, the Wobbe index can be between 50,04 and 50,76 MJ/mn
  3 (0 °C)/13,9-14,1 kWh/mn
  3 (0 °C).

2

n

3

n

3

(3)  It is permitted to inject biogas upgraded to natural gas quality, i.e. upgraded biogas with a Wobbe index between a minimum of 50,76 MJ/mn
  3 (0 °C)/and a maximum of 55,80 MJ/mn
  3 (0 °C).

3

n

3

n

3

---
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4652 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 4652

To provide Medicare beneficiaries with access to prescription drugs at 
                    Federal Supply Schedule prices.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 22, 2005

  Mr. Stupak introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
To provide Medicare beneficiaries with access to prescription drugs at 
                    Federal Supply Schedule prices.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ACCESS OF MEDICARE BENEFICIARIES TO PRESCRIPTION DRUGS AT 
              FEDERAL SUPPLY SCHEDULE PRICES.

    Notwithstanding any other provision of law, any individual who is 
entitled to benefits under part A, or enrolled under part B, of title 
XVIII of the Social Security Act shall be eligible to obtain 
prescription drugs at the prices specified in the Federal Supply 
Schedule.

SEC. 2. NEGOTIATING FAIR PRICES FOR MEDICARE PRESCRIPTION DRUGS ON 
              BEHALF OF MEDICARE BENEFICIARIES.

    Section 1860D-11 of the Social Security Act (42 U.S.C. 1395w-111) 
is amended by striking subsection (i) (relating to noninterference) and 
inserting the following:
    ``(i) Authority to Negotiate Prices With Manufacturers.--In order 
to ensure that beneficiaries enrolled under prescription drug plans and 
MA-PD plans pay the lowest possible price, the Secretary shall have 
authority similar to that of the Secretary of Veterans Affairs, 
Secretary of Defense, and the heads of other Federal agencies and 
departments that purchase prescription drugs in bulk to negotiate 
contracts with manufacturers of covered part D drugs, consistent with 
the requirements and in furtherance of the goals of providing quality 
care and containing costs under this part.''.
                                 <all>
```
No. 11-6678.

#### Alberto Concepcion, Petitioner v. Federal Bureau of Investigation, et al.

565 U.S. 1186, 132 S. Ct. 1164,

2012 U.S. LEXIS 964.

181 L. Ed. 2d 1033,

January 23, 2012.

Petition for rehearing denied.

Former decision, 565 U.S. 1067, 132 S. Ct. 778, 181 L. Ed. 2d 499, 2011 U.S. LEXIS 8541.